Yanming Du
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$2.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 18, 2026 | NIH | STTR Phase II Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | $1.0M | HARLINGENE LIFE SCIENCES LLC |
| Aug 20, 2025 | NIH | STTR Phase II Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | $1.0M | HARLINGENE LIFE SCIENCES LLC |
| Apr 8, 2024 | NIH | STTR Phase I Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | $300K | HARLINGENE LIFE SCIENCES LLC |
| Apr 10, 2023 | NIH | STTR Phase I Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection | $300K | HARLINGENE LIFE SCIENCES LLC |
| Jun 24, 2022 | NIH | STTR Phase I Developing Hepatoselective Hepatitis B Therapeutic Dihydroquinolizinone (DHQ) Molecules with Better Safety Profiles for Efficient HBsAg Reduction | $300K | HARLINGENE LIFE SCIENCES LLC |
Peer ranks
Federal funding#650
Awards as PI#417
Patents#273
Companies
- HARLINGENE LIFE SCIENCES LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.